|
CCDC86 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.753400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.725200E-01 |
| Normal-vs-Stage2 |
4.280800E-03 |
| Normal-vs-Stage3 |
5.702800E-01 |
| Normal-vs-Stage4 |
8.212000E-01 |
| Stage1-vs-Stage2 |
2.274100E-02 |
| Stage1-vs-Stage3 |
1.075840E-01 |
| Stage1-vs-Stage4 |
4.743000E-01 |
| Stage2-vs-Stage3 |
6.586400E-04 |
| Stage2-vs-Stage4 |
1.085790E-02 |
| Stage3-vs-Stage4 |
4.898000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.632400E-01 |
| Normal-vs-AfricanAmerican |
2.927800E-01 |
| Normal-vs-Asian |
9.611900E-02 |
| Caucasian-vs-AfricanAmerican |
3.601600E-01 |
| Caucasian-vs-Asian |
1.067000E-01 |
| AfricanAmerican-vs-Asian |
7.780800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.309000E-01 |
| Normal-vs-Female |
1.349750E-01 |
| Male-vs-Female |
4.960200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.125600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.323000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.295600E-02 |
| Normal-vs-Age(81-100Yrs) |
9.840600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.446400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.321800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.492000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.090100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.494800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.021400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.692400E-02 |
| Classical-VS-Follicular |
1.006360E-04 |
| Classical-VS-Other |
7.176600E-01 |
| Classical-VS-Normal |
7.226200E-01 |
| Tall-VS-Follicular |
5.98279999999285E-05 |
| Tall-VS-Other |
4.403800E-01 |
| Tall-VS-Normal |
1.360200E-01 |
| Follicular-VS-Other |
4.091000E-01 |
| Follicular-VS-Normal |
6.411600E-04 |
| Other-VS-Normal |
7.396200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.050300E-02 |
| Normal-vs-N1 |
2.957600E-01 |
| N0-vs-N1 |
2.141000E-03 |
|
|
